MetaCap

Bioventus Inc. Class A (BVS)

NASDAQ: BVSHealth CareMedical/Dental InstrumentsUSD

12.77-0.33 (-2.52%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 12.77 0.00%

BVS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$872.26M
52-week range
6.37 – 15.89
Day range
12.75 – 13.36
Volume / Avg
365.22K / 627.38K
Beta
—
Next earnings
Nov 3, 2026

52-week range

$6.37$15.89

BVS stock today

Shares of Bioventus (BVS) finished lower on Oct 7 at $12.77, a drop of 2.52% or $0.33 per share, versus the S&P 500's 0.22% decline. Shares are 19.7% below their 52-week high of $15.89, set on Aug 5, 2026 and 100.5% above the 52-week low of $6.37, in the middle of the past year's range. BVS is up 71.6% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 92.0%.

Bioventus trades at 16.8x its trailing twelve-month earnings per share of $0.76. Its forward P/E of 13.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Bioventus's next earnings report is expected on Nov 3, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Bioventus

Company profile
Industry
Medical/Dental Instruments
IPO year
2021

Earnings

Earnings history
Next report
Nov 3, 2026
EPS estimate
$0.17

Bioventus peers

Health Care sector
BVS peer companies
CompanyPrice% ChgMarket capCompare
TNDMTandem Diabetes Care Inc.15.84-1.98%$1.10Bvs BVS
IRMDiRadimed Corporation85.47+0.77%$1.09Bvs BVS
AORTArtivion Inc.21.61-1.05%$1.05Bvs BVS
PRCTPROCEPT BioRobotics Corporation17.91+2.28%$1.02Bvs BVS
IARTIntegra LifeSciences Holdings Corporation13.00-2.40%$1.01Bvs BVS
BBNXBeta Bionics Inc.18.08-2.95%$975.35Mvs BVS
DRTSAlpha Tau Medical Ltd.14.25-1.59%$1.32Bvs BVS
SIBNSI-BONE Inc.19.10-2.30%$856.03Mvs BVS

Indexes, lists and sector

Bioventus stock FAQ

What is Bioventus's stock price today?

BVS last traded at $12.77 as of Oct 7, 4:00 PM EDT, down 2.52% on the day. Prices are delayed at least 15 minutes.

When is Bioventus's next earnings date?

Bioventus is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.17.

What is BVS's P/E ratio?

BVS trades at a trailing P/E ratio of 16.80 and a forward P/E of 13.88.

What is the BVS 52-week high?

The 52-week high for BVS is $15.89 and the 52-week low is $6.37. The stock is currently 19.7% below its high.

Compare BVS